Literature DB >> 16824514

Effect of anandamide on nonadrenergic noncholinergic-mediated relaxation of rat corpus cavernosum.

Mehdi Ghasemi1, Hamed Sadeghipour, Ali R Mani, Sina Tavakoli, Amir Reza Hajrasouliha, Farzad Ebrahimi, Ahmad Reza Dehpour.   

Abstract

The purpose of this study was to investigate the effect of the endogenous cannabinoid anandamide on the nonadrenergic noncholinergic (NANC) relaxant responses to electrical field stimulation in isolated rat corpus cavernosum. The corporal strips were mounted under tension in a standard oxygenated organ bath with guanethidine sulfate (5 microM) and atropine (1 microM) (to produce adrenergic and cholinergic blockade). The strips were precontracted with phenylephrine hydrochloride (7.5 microM) and electrical field stimulation was applied at different frequencies to obtain NANC-mediated relaxation. The expression of CB1, CB2 and vanilloid receptor proteins within the rat corpus cavernosum was evaluated using western blot analysis. The results showed that the relaxant responses to electrical stimulation were significantly enhanced in the presence of anandamide at 1 and 3 microM. The potentiating effect of anandamide (1 microM) on relaxation responses was significantly attenuated by either the selective cannabinoid CB1 receptor antagonist N-(piperidin-1-yl)-5-(4-iodophenyl)-1-(2, 4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (AM251; 1 microM) or the vanilloid receptor antagonist capsazepine (3 microM), but not by the selective cannabinoid CB2 receptor antagonist 6-iodo-2-methyl-1-[2-(4-morpholinyl) ethyl]-1H-indol-3-yl (4-methoxyphenyl)methanone (AM630; 1 microM). Neither of these antagonists had influence on relaxation responses. Indomethacin (20 microM) had no effect on NANC-mediated relaxation in the presence or absence of anandamide (1 microM). Preincubation with Nw-Nitro-L-Arginine Methyl Ester (L-NAME; 1 microM) significantly inhibited the relaxation responses in the presence or absence of 1 microM anandamide. Although at 30 nM, L-NAME did not cause a significant inhibition of relaxant responses individually, it significantly inhibited the potentiating effect of anandamide (1 microM) on relaxation responses. Anandamide (1 microM) had no influence on concentration-dependent relaxant responses to sodium nitroprusside (10 nM-1 mM), a nitric oxide (NO) donor. The western blotting of corporal tissues demonstrated the existence of both vanilloid and CB1 receptors in corporal strips. In conclusion, our results showed that anandamide has a potentiating effect on NANC-mediated relaxation of rat corpus cavernosum through both CB1 and vanilloid receptors and the NO-mediated component of the NANC relaxant responses to electrical stimulation is involved in this enhancement.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16824514     DOI: 10.1016/j.ejphar.2006.06.002

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

Review 1.  TRPV1 in male reproductive system: focus on sperm function.

Authors:  Wanglong Xiao; Ying Chen
Journal:  Mol Cell Biochem       Date:  2022-05-20       Impact factor: 3.396

2.  Effects of cannabinoid and vanilloid receptor antagonists on nicotine induced relaxation response enhancement in rabbit corpus cavernosum.

Authors:  Ismail Mert Vural; Gokce Sevi Ozturk Fincan; Derya Sebile Koc; Yagmur Okcay; Celil Ilker Askin; Ayse Kubra Kibar; Sevil Ozger Ilhan; Yusuf Sarioglu
Journal:  Iran J Basic Med Sci       Date:  2022-04       Impact factor: 2.532

3.  Role of the nitric oxide pathway and the endocannabinoid system in neurogenic relaxation of corpus cavernosum from biliary cirrhotic rats.

Authors:  M Ghasemi; H Sadeghipour; H Shafaroodi; B G Nezami; T Gholipour; A R Hajrasouliha; S Tavakoli; M Nobakht; K P Moore; A R Mani; A R Dehpour
Journal:  Br J Pharmacol       Date:  2007-05-08       Impact factor: 8.739

4.  PnPP-19, a spider toxin peptide, induces peripheral antinociception through opioid and cannabinoid receptors and inhibition of neutral endopeptidase.

Authors:  A C N Freitas; D F Pacheco; M F M Machado; A K Carmona; I D G Duarte; M E de Lima
Journal:  Br J Pharmacol       Date:  2016-03-10       Impact factor: 8.739

Review 5.  Lithium and Erectile Dysfunction: An Overview.

Authors:  Mohammad Sheibani; Mehdi Ghasemi; Ahmad Reza Dehpour
Journal:  Cells       Date:  2022-01-05       Impact factor: 6.600

6.  Treatment with CB2 agonist JWH-133 reduces histological features associated with erectile dysfunction in hypercholesterolemic mice.

Authors:  Rodrigo Araujo Fraga-Silva; Fabiana Pereira Costa-Fraga; Fabrizio Montecucco; Younouss Faye; Silvia Quintao Savergnini; Sébastien Lenglet; François Mach; Sabine Steffens; Nikolaos Stergiopulos; Robson Augusto Souza dos Santos; Rafaela Fernandes da Silva
Journal:  Clin Dev Immunol       Date:  2013-11-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.